RU95115547A - Стероидные соединения, способы их получения и фармацевтический препарат - Google Patents

Стероидные соединения, способы их получения и фармацевтический препарат

Info

Publication number
RU95115547A
RU95115547A RU95115547/04A RU95115547A RU95115547A RU 95115547 A RU95115547 A RU 95115547A RU 95115547/04 A RU95115547/04 A RU 95115547/04A RU 95115547 A RU95115547 A RU 95115547A RU 95115547 A RU95115547 A RU 95115547A
Authority
RU
Russia
Prior art keywords
compounds
synthesis
methods
gcs
glucocorticosteroids
Prior art date
Application number
RU95115547/04A
Other languages
English (en)
Inventor
Леннарт Браттсанд Ральф
Se]
Эдман Петер
Хегберг Томас
Нильссон Стинабритт
Арне Тален Брор
Эрик Ульмиус Ян
Original Assignee
Астра Актиеболаг (SE)
Астра Актиеболаг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9300030A external-priority patent/SE9300030D0/xx
Priority claimed from SE9300082A external-priority patent/SE9300082D0/xx
Application filed by Астра Актиеболаг (SE), Астра Актиеболаг filed Critical Астра Актиеболаг (SE)
Publication of RU95115547A publication Critical patent/RU95115547A/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/0026Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Описываются новые соединения, являющиеся глюкокортикостероидами (ГКС), химически связанными с сахарами и соответствующие общей формуле ГКС-О-Сахар, предназначенные для доставки специфичных к ободочной кишке или подвздошной кишке ГКС, к воспаленной слизистой кишечника. Описываются также способы получения этих соединений, фармацевтические препараты, содержащие эти соединения, и использование указанных соединений в медицине.

Claims (1)

  1. Описываются новые соединения, являющиеся глюкокортикостероидами (ГКС), химически связанными с сахарами и соответствующие общей формуле ГКС1-О-Сахар1, предназначенные для доставки специфичных к ободочной кишке или подвздошной кишке ГКС, к воспаленной слизистой кишечника. Описываются также способы получения этих соединений, фармацевтические препараты, содержащие эти соединения, и использование указанных соединений в медицине.
RU95115547/04A 1993-01-08 1993-12-17 Стероидные соединения, способы их получения и фармацевтический препарат RU95115547A (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9300030A SE9300030D0 (sv) 1993-01-08 1993-01-08 Novel colon- or ileum-specific steroid derivatives
SE9300030-5 1993-01-08
SE9300082A SE9300082D0 (sv) 1993-01-14 1993-01-14 Novel colon- or ileum-specific steroid derivatives
SE9300082-6 1993-01-14

Publications (1)

Publication Number Publication Date
RU95115547A true RU95115547A (ru) 1997-06-10

Family

ID=26661623

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95115547/04A RU95115547A (ru) 1993-01-08 1993-12-17 Стероидные соединения, способы их получения и фармацевтический препарат

Country Status (22)

Country Link
US (2) US5908833A (ru)
EP (1) EP0678097B1 (ru)
JP (1) JP3366640B2 (ru)
KR (1) KR960700266A (ru)
AT (1) ATE183192T1 (ru)
BR (1) BR9307746A (ru)
CA (1) CA2152374A1 (ru)
CZ (1) CZ171095A3 (ru)
DK (1) DK0678097T3 (ru)
ES (1) ES2137353T3 (ru)
FI (1) FI953358A0 (ru)
GR (1) GR3031789T3 (ru)
HU (1) HU221584B (ru)
IS (1) IS4111A (ru)
LV (1) LV10961B (ru)
NO (1) NO305367B1 (ru)
NZ (1) NZ259596A (ru)
PL (1) PL178307B1 (ru)
RU (1) RU95115547A (ru)
SK (1) SK87295A3 (ru)
TW (1) TW261615B (ru)
WO (1) WO1994015947A1 (ru)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2152374A1 (en) * 1993-01-08 1994-07-21 Ralph Lennart Brattsand Novel colon- or ileum-specific steroid derivatives
CA2172983A1 (en) * 1993-09-29 1995-04-06 Kei Sugai 21-substituted steroid compound
US6028190A (en) 1994-02-01 2000-02-22 The Regents Of The University Of California Probes labeled with energy transfer coupled dyes
US6166024A (en) 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
JP4610734B2 (ja) * 1998-03-19 2011-01-12 三笠製薬株式会社 21−置換グリコシルステロイド化合物
US20030083231A1 (en) * 1998-11-24 2003-05-01 Ahlem Clarence N. Blood cell deficiency treatment method
CZ20013912A3 (cs) 1999-05-04 2002-05-15 Strakan Limited Androgen glykosid, sloučenina, testosteron-ß-D-glukosid, 5 alfa-Dihydrotestosteron- 17ß-D-glukosid, farmaceutický prostředek a pouľití sloučeniny
TR200200562T2 (tr) 1999-06-14 2002-05-21 Cosmo S.P.A Vücutta kontrollü şekilde salgılanabilen ve nahoş tadı önleyebilen ağızdan alınmaya mahsus farmasötik bileşimler
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
WO2001051057A2 (en) * 2000-01-14 2001-07-19 Strakan Limited Glycosides and orthoester glycosides of glucocorticoids and uses thereof
SE0101220D0 (sv) * 2001-04-04 2001-04-04 Astrazeneca Ab New use
EP1625854B1 (en) * 2004-08-09 2008-10-15 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Albumin conjugates containing a glucuronic linker
US20080200441A1 (en) * 2007-02-14 2008-08-21 University Of Southern California Estrogen receptor modulators associated pharmaceutical compositions and methods of use
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
CN115651056A (zh) 2016-11-08 2023-01-31 里珍纳龙药品有限公司 类固醇类化合物及其蛋白质-偶联物
ES2968413T3 (es) * 2017-03-30 2024-05-09 Fruithy Holdings Ltd Compuesto de glicósido de lactulosa, procedimiento de preparación y utilización del mismo
CN110944718A (zh) 2017-05-18 2020-03-31 里珍纳龙药品有限公司 环糊精蛋白质药物偶联物
BR112020013492A2 (pt) * 2018-01-08 2020-12-08 Regeneron Pharmaceuticals, Inc. Esteroides e conjugados de anticorpo dos mesmos
BR112020022400A2 (pt) 2018-05-09 2021-02-02 Regeneron Pharmaceuticals, Inc. anticorpos anti-msr1 e métodos de uso dos mesmos

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE378109B (ru) * 1972-05-19 1975-08-18 Bofors Ab
US3996359A (en) * 1972-05-19 1976-12-07 Ab Bofors Novel stereoisomeric component A of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steroid 21-acylates, compositions thereof, and method of treating therewith
US3992534A (en) * 1972-05-19 1976-11-16 Ab Bofors Compositions and method of treating with component B of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steriods
SE378110B (ru) * 1972-05-19 1975-08-18 Bofors Ab
US3938233A (en) * 1974-08-12 1976-02-17 Cannon Robert B Heat transfer apparatus
DE2803660A1 (de) * 1978-01-25 1979-07-26 Schering Ag Neue in 17-position substituierte steroide der pregnanreihe, ihre herstellung und verwendung
BG33738A3 (en) * 1978-01-25 1983-04-15 Schering Aktiengesellschaft Method for obtaining of substituated in 17- th position steroids from pregnan row
US4221787A (en) * 1978-03-28 1980-09-09 Interx Research Corporation Esteramide prodrugs of anti-inflammatory corticosteroids
SE8008524L (sv) * 1980-12-04 1982-06-05 Draco Ab 4-pregnen-derivat, ett forfarande for deras framstellning, beredning och metod for behandling av inflammatoriska tillstand
US4456602A (en) * 1982-08-23 1984-06-26 The Upjohn Company Amine containing ester prodrugs of corticosteroids
US4443440A (en) * 1982-08-30 1984-04-17 The Upjohn Company Amine containing ester prodrugs of corticosteroids
US4472392A (en) * 1983-01-21 1984-09-18 The Upjohn Company Sulfonate containing ester prodrugs of corticosteroids
US4469689A (en) * 1983-03-30 1984-09-04 The Upjohn Company Sulfonate containing ester prodrugs of corticosteroids
WO1984004041A1 (en) * 1983-04-14 1984-10-25 Univ California Colon-specific drug delivery system
US4548922A (en) * 1983-06-06 1985-10-22 Beth Israel Hospital Drug administration
US4959358A (en) * 1983-06-06 1990-09-25 Beth Israel Hospital Assn. Drug administration
SE8306370D0 (sv) * 1983-11-18 1983-11-18 Draco Ab Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions
US4588718A (en) * 1984-03-28 1986-05-13 The Upjohn Company Carboxy containing ester prodrugs of corticosteroids
SE8403905D0 (sv) * 1984-07-30 1984-07-30 Draco Ab Liposomes and steroid esters
US5215979A (en) * 1985-12-19 1993-06-01 Aktiebolaget Draco 16,17-acetalsubstituted pregnane 21-oic acid derivatives
GB8600490D0 (en) * 1986-01-09 1986-02-12 Erba Farmitalia Aminoglycoside norcholanic acid lactams
GB8600491D0 (en) * 1986-01-09 1986-02-12 Erba Farmitalia Aminoglycoside norcholanic acid derivatives
GB8600489D0 (en) * 1986-01-09 1986-02-12 Erba Farmitalia Aminoglycoside steroids
EP0267297B1 (en) * 1986-05-12 1993-09-15 Mect Corporation Sialosylcholesterol, process for its preparation, and drug for treating diseases of nervous system
CA1299653C (en) * 1988-07-07 1992-04-28 Markwell Medical Institute, Inc. Biological fluid measuring device
SE8903914D0 (sv) * 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
US5643602A (en) * 1989-11-22 1997-07-01 Astra Aktiebolag Oral composition for the treatment of inflammatory bowel disease
SE9100341D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroids
SE9100342D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroid esters
US5888995A (en) * 1991-02-04 1999-03-30 Astra Aktiebolag Steroid esters
WO1993022334A1 (en) * 1992-05-04 1993-11-11 Sri International Pharmaceutical compositions and methods for colonic delivery of corticosteroids
CA2152374A1 (en) * 1993-01-08 1994-07-21 Ralph Lennart Brattsand Novel colon- or ileum-specific steroid derivatives

Also Published As

Publication number Publication date
BR9307746A (pt) 1995-11-14
US6140308A (en) 2000-10-31
PL309777A1 (en) 1995-11-13
JP3366640B2 (ja) 2003-01-14
HUT73227A (en) 1996-07-29
AU5844794A (en) 1994-08-15
ES2137353T3 (es) 1999-12-16
US5908833A (en) 1999-06-01
ATE183192T1 (de) 1999-08-15
KR960700266A (ko) 1996-01-19
LV10961B (en) 1996-08-20
EP0678097A1 (en) 1995-10-25
NZ259596A (en) 1997-04-24
NO952683L (no) 1995-07-06
JPH08505616A (ja) 1996-06-18
PL178307B1 (pl) 2000-04-28
LV10961A (lv) 1995-12-20
NO305367B1 (no) 1999-05-18
CZ171095A3 (en) 1996-01-17
FI953358A (fi) 1995-07-07
IS4111A (is) 1994-07-09
FI953358A0 (fi) 1995-07-07
AU678803B2 (en) 1997-06-12
EP0678097B1 (en) 1999-08-11
HU9502087D0 (en) 1995-09-28
NO952683D0 (no) 1995-07-06
DK0678097T3 (da) 2000-02-07
GR3031789T3 (en) 2000-02-29
WO1994015947A1 (en) 1994-07-21
SK87295A3 (en) 1996-04-03
HU221584B (hu) 2002-11-28
CA2152374A1 (en) 1994-07-21
TW261615B (ru) 1995-11-01

Similar Documents

Publication Publication Date Title
RU95115547A (ru) Стероидные соединения, способы их получения и фармацевтический препарат
HUP0203745A2 (en) Amphiphilic drug-oligomer conjugates with hydrolyzable lipophile components and methods for making and using the same
IT1245890B (it) Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
KR19990087113A (ko) 약품으로 인한 독성을 경감할 수 있는 산화질소 도너
ATE35136T1 (de) Neue benzisoselenazolone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
KR870700599A (ko) 카르복실산유도체, 그의 제조방법, 이화합물을 함유한 약제조성물 및 그의 용도
BR0008076A (pt) 16-hidroxiestratrienos como estrogênios de efeito seletivo
BR0012610A (pt) Novo derivado de difenilpiperidina
Van Hees et al. Influence of intestinal transit time on azo-reduction of salicylazosulphapyridine (Salazopyrin).
CA2120062A1 (en) Use of Sulodexide and of Medicines Containing It in the Treatment of Diabetic Nephropathy
BR0311866A (pt) Composições de saponinas ou sapogeninas para terapia de câncer
Säwe et al. Glucuronidation of morphine in human liver and interaction with oxazepam
Hundt et al. Post-mortem serum concentration of cantharidin in a fatal case of cantharides poisoning
ATE27157T1 (de) Cycloalkylderivate von benzisoselenazolonen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
EP0924219A3 (en) Novel estrenes for inducing hypothalamic effects
Gao et al. Ten-year Follow-up of a Patient with Multicentric Reticulo-histiocytosis associated with Myopathy
GB1483650A (en) Pharmaceutical preparations based on mesterolone
ATE365172T1 (de) Konjugate von dna-bindenden verbindungen mit steroidhormonen und ihre verwendung als transfektionsmittel
MX9700881A (es) Pregnanos y colanos como indicadores neuroquimicos del cambio en la funcion hipotalamica.
Koechel et al. Synthesis and pharmacology of an epoxide derivative of ethacrynic acid
Kemball‐Cook et al. Fractionation of human antibody to factor VIII: C: an IRMA for phospholipid binding sites on factor VIII C: Ag
Schröter et al. Reticulosis as a long-term side-effect of methotrexate therapy in a patient with generalized psoriasis and psoriatic arthritis
Thigpen High-dose chemotherapy with autologous bone marrow support in ovarian carcinoma: the bottom line, more or less
US3546261A (en) Novel ethoxylated acetic acid esters of pregnane-21-ols
FR2385738A1 (fr) Nouveaux steroides de la serie de l'androstane, leur preparation et leur utilisation dans le traitement des troubles dermatologiques